Advancing Treatments for Rare Eye Diseases in Europe
Restore Vision is a project funded by the European Commission aiming to develop and test new treatments for 7 rare eye diseases (REDs). The consortium joins 10 European key players on rare eye diseases and is led by University of Galway.About Restore Vision
people suffer from blindness and visual impairment
About Restore Vision
Over the the next 4 years (2023-2027) the Restore Vision consortium will explore new treatments for 7 REDs by repurposing existing generic drugs, developing new theurapeutic compounds, and conducting pioneering clinical trials to ensure their safety and effectiveness.Learn more about our work
Project in numbers
EUR in funding
Read Restore Vision’s latest news.
Interested in Restore vision?
Restore vision is a EU-funded project working on developing new treatments for rare eye diseases. If you’re interested in collaborating or knowing more, send us a message.